Jean-Frédéric Viret
Directeur Financier/CFO chez NGM BIOPHARMACEUTICALS, INC.
Profil
Jean-Frédéric Viret is currently the Chief Financial Officer at NGM Biopharmaceuticals, Inc. Prior to his current position, he held various roles including Associate Director-Finance at Tularik, Inc., Director at RubrYc Therapeutics, Inc., Senior Associate at PricewaterhouseCoopers LLP, Chief Financial Officer & Vice President at Anesiva, Inc., Chief Financial Officer at CareDx, Inc., Trustee at International School of The Peninsula, Chief Financial Officer at Diadexus, Inc., Chief Financial Officer at Coherus BioSciences, Inc., and President at JV Consulting.
Dr. Viret obtained an MBA from Cornell University, a doctorate from the University of Strasbourg, and an undergraduate degree from Institut National Polytechnique de Lorraine.
Postes actifs de Jean-Frédéric Viret
| Sociétés | Poste | Début |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/11/2023 |
Anciens postes connus de Jean-Frédéric Viret
| Sociétés | Poste | Fin |
|---|---|---|
| COHERUS BIOSCIENCES, INC. | Directeur Financier/CFO | 07/03/2021 |
| DIADEXUS, INC. | Directeur Financier/CFO | 19/09/2014 |
| CAREDX, INC | Directeur Financier/CFO | 01/02/2012 |
Formation de Jean-Frédéric Viret
| Cornell University | Masters Business Admin |
| University of Strasbourg | Doctorate Degree |
| Institut National Polytechnique de Lorraine | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CAREDX, INC | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Anesiva, Inc.
 Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
RubrYc Therapeutics, Inc.
 RubrYc Therapeutics, Inc. BiotechnologyHealth Technology RubrYc Therapeutics, Inc. develops antibody therapy applications. Its products include RubrYc Discovery Engine, through which people can decode protein interactions through the integration of data and biological science. The company was founded in 2017 and is headquartered in San Carlos, CA. | Health Technology |
